Abiopharma

News list

Director Ryan Charles E 🟢 acquired 1.4K shares of Nebius Group N.V. (NBIS) Transaction Date: Sep 01, 2026 | Filing ID: 000108

Full text

News bot Sept. 3, 2026, 3:20 p.m.
🔍 Ryan Charles E (Director)

Company: Nebius Group N.V. (NBIS)

Report Date: 2026-09-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 1,352
Detailed Transactions and Holdings:
- Acquired 1,352 shares of Class A Shares (Direct)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 273,885.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents restricted share units ("RSUs") granted on September 1, 2026 under the Company's Amended and Restated Equity Incentive Plan, as amended on August 15, 2024. The RSUs vest in full on January 2, 2027. Each RSU represents a right to receive one Class A Share of Nebius upon vesting.
- REMARKS: Due to the issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Act, the reporting person's transactions in the issuer's equity securities are exempt from Sections 16(b) and 16(c) of the Act.